ReviewFrontiers in pharmacology2020

Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases.

Juan Decara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.